Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Faivre

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|October 26, 2000
Oxaliplatin in colorectal cancer: an overviewJ P Armand, V Boige, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancerC Monnerat, R Henriksson, T Le Chevalier, et al.
Molecular Pharmacology|July 17, 2001
Suppression of cellular invasion by activated G-protein subunits Galphao, Galphai1, Galphai2, and Galphai3 and sequestration of GbetagammaS Faivre, K Régnauld, E Bruyneel, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 10, 2001
[Epidermoid carcinoma of the head and neck: contribution of chemotherapy in case of recurrence and locally advanced disease. Review of the literature]A Hasbini, C Durdux, S Faivre, et al.
British Journal of Cancer|March 10, 2001
Detection of circulating carcinoma cells by telomerase activityL R Gauthier, C Granotier, J C Soria, et al.
Anti-Cancer Drugs|April 1, 1997
Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming unitsE Raymond, A Hanauske, S Faivre, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Oncoimmunology|December 10, 2020
PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinomaD Evrard, M Hourseau, A Couvelard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I and pharmacokinetic study of the novel aza-anthracenedione compound BBR 2778 in patients with advanced solid malignanciesS Faivre, E Raymond, V Boige, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|October 26, 2000
Oxaliplatin in colorectal cancer: an overviewJ P Armand, V Boige, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancerC Monnerat, R Henriksson, T Le Chevalier, et al.
Molecular Pharmacology|July 17, 2001
Suppression of cellular invasion by activated G-protein subunits Galphao, Galphai1, Galphai2, and Galphai3 and sequestration of GbetagammaS Faivre, K Régnauld, E Bruyneel, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 10, 2001
[Epidermoid carcinoma of the head and neck: contribution of chemotherapy in case of recurrence and locally advanced disease. Review of the literature]A Hasbini, C Durdux, S Faivre, et al.
British Journal of Cancer|March 10, 2001
Detection of circulating carcinoma cells by telomerase activityL R Gauthier, C Granotier, J C Soria, et al.
Anti-Cancer Drugs|April 1, 1997
Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming unitsE Raymond, A Hanauske, S Faivre, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Oncoimmunology|December 10, 2020
PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinomaD Evrard, M Hourseau, A Couvelard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I and pharmacokinetic study of the novel aza-anthracenedione compound BBR 2778 in patients with advanced solid malignanciesS Faivre, E Raymond, V Boige, et al.
Pageof 7